Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Thomas Catinazzo Insider Profile
4 Followers
Thomas Catinazzo, CFO at Relay Therapeutics, holds 330.43K shares in Relay Therapeutics (Ticker: RLAY).
Profitable Transactions
21 out of 21 Profitable Transactions
Average Return
+39.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Thomas Catinazzo's holdings
Insider Roles
CFO
Roles that Thomas Catinazzo holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Nov 01, 2022 - Nov 01, 2023
Return:+69.50%
The most profitable trade made by Thomas Catinazzo
Thomas Catinazzo's Trading History
List of latest transactions for each holding click on a transaction to see Thomas Catinazzo's performance on stock
You May Also Like
Thomas Catinazzo insider profile FAQ
What is the percentage of profitable transactions made by Thomas Catinazzo?
The percentage of profitable transactions made by Thomas Catinazzo is 100%.
What is the average return per transaction made by Thomas Catinazzo?
The average return per transaction made by Thomas Catinazzo is 39.00%.
What stocks does Thomas Catinazzo hold?
Thomas Catinazzo holds: RLAY stocks.
What was Thomas Catinazzo’s latest transaction?
Thomas Catinazzo latest transaction was an Uninformative Sell of $56.65K.
What was Thomas Catinazzo's most profitable transaction?
Thomas Catinazzo’s most profitable transaction was an Informative Sell of RLAY stock on November 1, 2022. The return on the trade was 69.50%.
What is Thomas Catinazzo's role in Relay Therapeutics?
Thomas Catinazzo's role in Relay Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.